Australia's most trusted
source of pharma news
Friday, 29 August 2025
Posted 27 August 2025 AM
Four pharmas are forecast to outrun Roche in worldwide prescription drug sales, sending the company down the leaderboard by the end of the decade.
Numbers crunched by Evaluate in its latest report reveals the potential rise and fall of the top 10 companies from 2024 to 2030.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.